The Indian scientific community has achieved a historic milestone by creating AdFalciVax as the nation's first homegrown ...

India licenses its first indigenous malaria vaccine, AdFalciVax, aiming to boost efforts toward malaria elimination by 2030.

Turning to dengue, Shri Nadda noted that all States and UTs (except Ladakh) are endemic to dengue and chikungunya.

The vector-borne disease count continues to rise in the city, with 33 more malaria and four chikungunya cases reported last week. Union hea.

Delhi has recorded its highest number of Malaria and Chikungunya cases in five years, with 297 and 46 cases respectively till mid-September.

Indian Council of Medical Research licenses manufacturers for indigenous malaria vaccine to combat malaria transmission in ...

The ICMR has licensed AdFalciVax, India's first indigenous multi-stage malaria vaccine, to five companies. Developed by the ...

Union Health Minister JP Nadda recently reviewed Delhi's dengue preparedness amid rising cases, urging intensified vector control and community engagement.

Nadda directs States, local bodies and hospitals to strengthen preparedness against vector-borne diseases, highlights ...

The ICMR has licensed its multi-stage malaria vaccine AdFalciVax to five companies — Indian Immunologicals Limited, ...

Nagpur: A major anti-malaria campaign was launched in Gadchiroli district through TCI Foundation, backed by Global Fund, ...

Tuberculosis was the leading infectious cause of death in India between 2021 and 2023, claiming more lives than malaria or ...